Equities
Global active equity platform: High-conviction strategies for long-term growth
Why Janus Henderson Investors for active equity investing?
Janus Henderson’s global active equity platform delivers high-conviction strategies designed to help clients achieve long-term growth and risk-adjusted returns.
Our experienced investment professionals leverage deep fundamental research and global insights to build equity solutions that aim to outperform benchmarks.
Active platform, global reach
Focused investment expertise
A history of delivering performance for clients
Our equity platform
Institutional-grade equity solutions
Active equity solutions powered by deep research, global expertise, and tailored portfolio design to help institutions achieve long-term, risk-adjusted returns
154
Equities investment professionals
20
Average years' experience
As at Jun 30, 2026
Meet our leaders
Invest in a brighter future today today
Investment heads Marc Pinto, CFA and Lucas Klein discuss the Janus Henderson difference: where world-class investment talent meets a commitment to your financial goals.
Hear them outline how our disciplined approach to equities, focused on rigorous stock selection and risk management, is driven by an unwavering dedication to active investing.
Equities strategies
We offer actively managed equity portfolios spanning sectors, geographies, and market caps.
| Name | About this product |
|---|---|
| International Alpha Equity | Invests in international companies where we believe the market underestimates free-cash-flow growth, with the aim to derive independent and uncorrelated sources of alpha. |
| Global Alpha Equity | By investing in global companies across the market-cap and style spectrum, we seek to deliver consistently good risk-adjusted returns, not sporadically great results. |
| Global Research Growth Equity | Sector specialists conduct independent research to create a high-conviction portfolio of best ideas around the globe, regardless of market cap or sub-sector. |
| Global Small Cap | Invests in small companies listed globally, seeking long-term capital growth by identifying good quality but potentially undervalued stocks. |
| Global Research Equity | Our research team scours the globe to construct a portfolio of best ideas, regardless of market cap, geography or subsector. |
| International Research Equity | Sector specialists conduct independent research to create a high-conviction portfolio of best ideas around the globe, regardless of market cap or sub-sector. |
| US Concentrated Growth | A differentiated view from the market that focuses on identifying sustainable, competitively advantaged companies that we believe will position our investments to outperform the index over time. |
| US Mid Cap Growth | A differentiated mid-cap growth strategy that takes a moderate approach to an asset class known for rapid growth potential. |
| US Mid Cap Value | Defensive mid-cap value equities. |
| US Opportunistic Alpha | The strategy seeks to invest with conviction in durable business models that can drive long-term capital appreciation. |
| Emerging Markets Innovation | An emerging markets equity strategy seeking growth opportunities across the three phases of innovation – building, scaling, and compounding. |
| Japan All Cap Equity | For investors seeking quality growth and cash-flow positive businesses with deep, local insight. |
| US SMID Cap Value | Defensive small-mid cap value equities. |
| US Research Core Equity | Sector specialists conduct independent research to create a high-conviction portfolio of best ideas, regardless of market cap or sub-sector. |
| US Small Cap Value | Defensive small-cap U.S. value equities. |
| US Research Growth Equity | Sector specialists conduct independent research to create a high-conviction portfolio of best ideas around the globe, regardless of market cap or sub-sector. |
| US Small Cap Growth | Our in-depth fundamental research strategy seeks resilient small-cap companies using their competitive advantages to grow over a multi-year time frame. |
| US SMID Cap Growth | Our in-depth fundamental research strategy seeks differentiated small-cap companies with the potential to quickly grow into mid-size companies. |
| Biotechnology Innovation | A biotechnology strategy that seeks to leverage a disciplined approach to identify compelling opportunities across the biotech landscape in both public and private investments. |
| Global Life Sciences | By understanding the science and business of health care, our experienced team seeks to invest in companies addressing unmet medical needs or improving efficiencies. |
| Global Property Equities | A high-conviction, bottom-up, long-only portfolio of global REIT companies seeking income and long-term capital appreciation. |
| Global Sustainable Equity | By focusing on companies that contribute to the development of a more sustainable global economy, our low-carbon investment approach aims to deliver compounding growth and attractive investment returns. |
| Global Technology and Innovation | Our deep and experienced tech team seeks growth through innovation in this complex and dynamic sector. |
| U.S. Real Estate Securities | Our team of real estate specialists use in-depth market knowledge to create a truly active, high-conviction portfolio intentionally different than the benchmark. |
| All-Cap Emerging Market Equity | A style-agnostic emerging markets strategy that blends top-down macro analysis with bottom-up stock selection to identify attractive opportunities in a volatile asset class. |
| Concentrated Europe Equity | For investors seeking long-term capital growth from an actively managed concentrated portfolio of mainly large and mid-cap European companies. |
Insights delivered to your inbox
Our latest thinking on the themes shaping today's investment landscape, delivered every two weeks.